NCT06335069 2025-09-24
18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
Maastricht University Medical Center
Phase 2 Recruiting
Clinical Trials
5 trialsNCT04605575 2022-04-26
Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT01499160 2022-02-11
Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer
University of Maryland, Baltimore
Phase 2 Terminated
NCT03910712 2019-04-10
Pyrotinib
Peking Union Medical College Hospital
Phase 2 Unknown
NCT01043913 2010-01-07
Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue
Faculdade de Medicina do ABC
Phase 2 Completed